Standout Papers
- Skin immune sentinels in health and disease (2009)
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials (2015)
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis (2016)
- Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model (2004)
- Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin (1994)
Immediate Impact
13 by Nobel laureates 23 from Science/Nature 95 standout
Citing Papers
Psoriasis
2021 Standout
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
2021 Standout
Works of Brian J. Nickoloff being referenced
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
2016 Standout
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
2015 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Brian J. Nickoloff | 8902 | 5489 | 5273 | 236 | 18.7k | |
| Thomas S. Kupper | 11039 | 5117 | 3646 | 244 | 19.0k | |
| Enno Christophers | 9842 | 5808 | 3605 | 357 | 18.5k | |
| Bernhard Homey | 11236 | 6594 | 4332 | 261 | 22.6k | |
| Frank O. Nestlé | 18020 | 7052 | 4866 | 197 | 23.5k | |
| Mark R. Pittelkow | 3436 | 5853 | 5195 | 360 | 18.8k | |
| Jóhann E. Guðjónsson | 8600 | 5077 | 2855 | 261 | 13.2k | |
| James T. Elder | 5263 | 2964 | 4224 | 174 | 11.0k | |
| Kunihiko Tamaki | 4114 | 3336 | 2538 | 271 | 11.1k | |
| Klaus Wolff | 4155 | 3115 | 2902 | 180 | 11.7k | |
| Steven F. Ziegler | 20187 | 5027 | 4140 | 238 | 30.2k |
All Works
Loading papers...